Related Experiment Video
Updated: Jul 7, 2026
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Totally implanted vascular access devices-related infections in oncology and hematology: A retrospective
Klaudia Misterka1, Maciej Latos2
1Infection Control Team, Warsaw Children Hospital, Warsaw, Poland.
Introduction:
The use totally implantable venous access devices (TIVAD) has significantly improved the quality of care and comfort of life of oncology patients.
Aim:
The aim of this study was to retrospectively analyze the incidence and etiology of infections in patients with TIVAD, with a distinction between oncology and hematology patients. In addition, the influence of age, tumour type, presence of neutropenia and palliative status on the prevalence of specific pathogens was assessed.
Materials And Methods:
The medical records of patients hospitalized in the oncology and haematology departments of the municipal hospital in Warsaw between 2022 and 2023 were retrospectively analysed. IBM SPSS Statistics 29 software was used for data analysis. Infection characteristics, age of patients, type of bacteria by type of cancer, type of bacteria versus age of patients, type of bacteria versus patient status are presented in tables.
Results:
On the Oncology ward there were 24 infections in 21 patients, while on the haematology ward there were 43 infections in 28 patients. On the Oncology ward, TIVAD infections occurred in 57.14% of patients with gastrointestinal cancer, while on the Haematology ward they occurred in 78.57% of patients with lymphoma. The results as infection density per inpatient TIVAD in oncology department it was 1.24 per 1000 person-days of TIVAD stay. In contrast, in the hematology department results as infection density per inpatient TIVAD it was 3.40. Gram-negative infections accounted for 80.60% (n = 54) and Gram-positive infections for 19.40% (n = 13). The distribution was similar in both wards (75.00% Gram-negative in oncology, 83.72% in haematology).
Conclusions:
Hematology patients were more likely to have TIVAD infections than oncology patients. In most studies, patients with solid tumours and hematological malignancies were analysed together, despite significant clinical differences. Therefore, we decided to analyze these two groups of patients separately.
More Related Videos
Related Concept Videos
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
01:29Endocarditis IV: Nursing Management
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
01:25Hemodialysis I: Introduction
01:24Hemodialysis II: Procedure and Complications